ArticleHuman reproduction open2019

A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids.

M P Diamond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.